VistaGen Therapeutics Receives Notice of Intention to Grant Patent for AV-101's Neuropathic Pain Treatment.
Medical Company Receives Special Notice For Its Neuropathic Treatment
Medical Company Receives Special Notice For…
Medical Company Receives Special Notice For Its Neuropathic Treatment
VistaGen Therapeutics Receives Notice of Intention to Grant Patent for AV-101's Neuropathic Pain Treatment.